<?xml version="1.0" ?>
<document id="062a18fe6bcaad19bd60d8b47d3287079a915545">
  <chunk id="062a18fe6bcaad19bd60d8b47d3287079a915545.c0" text="Clinical Features and Factors Associated with Outcomes of Patients Infected with a Novel Influenza A (H7N9) Virus: A Preliminary Study">
    <entity charOffset="89-98" id="062a18fe6bcaad19bd60d8b47d3287079a915545.c0.e0" ontology_id="DOID_8469" text="Influenza" type="disease"/>
  </chunk>
  <chunk id="062a18fe6bcaad19bd60d8b47d3287079a915545.c1" text="Objective: The present study aimed to analyze clinical features and factors associated with treatment outcomes of H7N9 influenza A virus infection.">
    <entity charOffset="119-128" id="062a18fe6bcaad19bd60d8b47d3287079a915545.c1.e0" ontology_id="DOID_8469" text="influenza" type="disease"/>
  </chunk>
  <chunk id="062a18fe6bcaad19bd60d8b47d3287079a915545.c2" text="Methods: The clinical progress in 18 H7N9-infected patients was monitored and recorded. The clinical features of H7N9 infection were noted and factors associated with treatment outcomes were analyzed by univariate analyses."/>
  <chunk id="062a18fe6bcaad19bd60d8b47d3287079a915545.c3" text="The average ages of patients in recovered and critical conditions were 67.0610.83 years and 72.75612.0 years, respectively. Renal insufficiency developed more frequently in critically ill patients (P = 0.023). The duration of traditional Chinese medicine (TCM) therapy was longer in recovered patients than in critically ill patients (P = 0.01). Laboratory tests showed that levels of C-reactive protein, serum creatinine, and myoglobin were significantly higher in critically ill patients than in recovered patients (P = 0.011, 0.04, and 0.016, respectively). Meanwhile, levels of all T cell subsets examined including total CD3 + , CD4 + , CD8 + , and CD45 + T cells were lower in critically ill patients than in recovered patients (P = 0.033, 0.059, 0.015, and 0.039, respectively). Logistic regression analysis demonstrated that C-reactive protein level, myoglobin level and TCM therapy duration were likely associated with treatment outcomes of H7N9 infection (P = 0.032, 0.041 and 0.017, respectively).">
    <entity charOffset="246-254" id="062a18fe6bcaad19bd60d8b47d3287079a915545.c3.e0" ontology_id="CHEBI_23888" text="medicine" type="chemical"/>
    <entity charOffset="256-259" id="062a18fe6bcaad19bd60d8b47d3287079a915545.c3.e1" ontology_id="CHEBI_145500" text="TCM" type="chemical"/>
    <entity charOffset="396-403" id="062a18fe6bcaad19bd60d8b47d3287079a915545.c3.e2" ontology_id="CHEBI_16541" text="protein" type="chemical"/>
    <entity charOffset="427-436" id="062a18fe6bcaad19bd60d8b47d3287079a915545.c3.e3" ontology_id="CHEBI_7044" text="myoglobin" type="chemical"/>
    <entity charOffset="844-851" id="062a18fe6bcaad19bd60d8b47d3287079a915545.c3.e4" ontology_id="CHEBI_16541" text="protein" type="chemical"/>
    <entity charOffset="859-868" id="062a18fe6bcaad19bd60d8b47d3287079a915545.c3.e5" ontology_id="CHEBI_7044" text="myoglobin" type="chemical"/>
    <entity charOffset="879-882" id="062a18fe6bcaad19bd60d8b47d3287079a915545.c3.e6" ontology_id="CHEBI_145500" text="TCM" type="chemical"/>
  </chunk>
  <chunk id="062a18fe6bcaad19bd60d8b47d3287079a915545.c4" text="Conclusion: Elderly people may have increased risk for H7N9 virus infection. T cell-mediated responses play an important role in defense against the H7N9 virus. C-reactive protein level, myoglobin level and TCM duration may be associated with treatment outcomes of H7N9 infection. Citation: Chen X, Yang Z, Lu Y, Xu Q, Wang Q, et al. (2013) Clinical Features and Factors Associated with Outcomes of Patients Infected with a Novel Influenza A (H7N9) Virus: A Preliminary Study. PLoS ONE 8(9): e73362.">
    <entity charOffset="121-125" id="062a18fe6bcaad19bd60d8b47d3287079a915545.c4.e0" ontology_id="CHEBI_50906" text="role" type="chemical"/>
    <entity charOffset="172-179" id="062a18fe6bcaad19bd60d8b47d3287079a915545.c4.e1" ontology_id="CHEBI_16541" text="protein" type="chemical"/>
    <entity charOffset="187-196" id="062a18fe6bcaad19bd60d8b47d3287079a915545.c4.e2" ontology_id="CHEBI_7044" text="myoglobin" type="chemical"/>
    <entity charOffset="207-210" id="062a18fe6bcaad19bd60d8b47d3287079a915545.c4.e3" ontology_id="CHEBI_145500" text="TCM" type="chemical"/>
    <entity charOffset="430-439" id="062a18fe6bcaad19bd60d8b47d3287079a915545.c4.e4" ontology_id="DOID_8469" text="Influenza" type="disease"/>
    <entity charOffset="482-485" id="062a18fe6bcaad19bd60d8b47d3287079a915545.c4.e5" ontology_id="CHEBI_58972" text="ONE" type="chemical"/>
    <pair e1="062a18fe6bcaad19bd60d8b47d3287079a915545.c4.e0" e2="062a18fe6bcaad19bd60d8b47d3287079a915545.c4.e4" id="062a18fe6bcaad19bd60d8b47d3287079a915545.c4.p0" relation="true"/>
    <pair e1="062a18fe6bcaad19bd60d8b47d3287079a915545.c4.e1" e2="062a18fe6bcaad19bd60d8b47d3287079a915545.c4.e4" id="062a18fe6bcaad19bd60d8b47d3287079a915545.c4.p1" relation="true"/>
    <pair e1="062a18fe6bcaad19bd60d8b47d3287079a915545.c4.e2" e2="062a18fe6bcaad19bd60d8b47d3287079a915545.c4.e4" id="062a18fe6bcaad19bd60d8b47d3287079a915545.c4.p2" relation="true"/>
    <pair e1="062a18fe6bcaad19bd60d8b47d3287079a915545.c4.e3" e2="062a18fe6bcaad19bd60d8b47d3287079a915545.c4.e4" id="062a18fe6bcaad19bd60d8b47d3287079a915545.c4.p3" relation="true"/>
    <pair e1="062a18fe6bcaad19bd60d8b47d3287079a915545.c4.e4" e2="062a18fe6bcaad19bd60d8b47d3287079a915545.c4.e5" id="062a18fe6bcaad19bd60d8b47d3287079a915545.c4.p4" relation="true"/>
  </chunk>
</document>
